RTP company engineers blood vessels
Growing spare body parts in the laboratory was a wild idea when Dr. Laura Niklason entered the field of tissue engineering. The former Duke University researcher who's now at Yale University remembered that even colleagues laughed in her face.

New artificial blood vessels could help a wider range of patients.
Researchers have developed artificial blood vessels that are derived from human cells but appear to have long shelf lives and are unlikely to provoke an immune response. Such vessels could someday prove valuable to patients undergoing heart-bypass operations, dialysis, or other procedures in which portions of blood vessels, or vascular grafts, may be needed.
Read Full Article

Humacyte announced today that data presented at the American Heart Association Scientific Sessions demonstrates the longevity and durability of acellular arterial bypass grafts.
Read Full Press Release

View Current News